CTSS and cancer: We first characterized cathepsin S expression and activity in human oral squamous cell carcinoma tissues and patient-matched normal oral mucosa using cathepsin S-specific antibodies and BMV157, an activity-based probe that enables the assessment of the proteolytically active fraction of cathepsin S. Total and active cathepsin S were increased in cancer tissues compared to normal tissues.